Abiopharma

🔍 Doheny Edward L II (Director)

Company: Core Natural Resources, Inc. (CNR)

Report Date: 2026-04-30

Detailed Transactions and Holdings:

• Acquired 1,390 shares of Common Stock, par value $0.01 per share ("Common Stock") (Direct)
  Date: 2026-04-30 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,390.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents a grant of restricted stock units pursuant to the Issuer's Omnibus Performance Incentive Plan, which vest on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
• F2: Of the 1,390 shares reported, 1,390 are unvested restricted stock units.